| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_92b582e867a1a9fb8100bf0d14abf385
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_faf522b8b83eded745c73018576219ba |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-05 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-216 |
| filingDate |
2008-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddcc6fdda50061441d8c4dfbec7962ae
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caa5221cdc55bda11fe386cebbc56c4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_956667d5d710eaf2cf245eafc9f431bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e41d5ca5e85d39f28aa35c5d599c7c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444fe1a05976e3177b7595f34988d7b7 |
| publicationDate |
2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2010095492-A |
| titleOfInvention |
Side-effect prevention substances for dyslipidemia drugs |
| abstract |
PROBLEM TO BE SOLVED: To suppress a side effect of a conventional fibrate agent which is a therapeutic agent for metabolic syndrome and lipid abnormality and improve the therapeutic effect. The substance for preventing side effects of a dyslipidemic agent according to the present invention is extracted from a microalga of Dunaliella genus that is administered in combination with a fibrate agent of the dyslipidemic agent and prevents side effects caused by the fibrate agent. It suppresses liver hypertrophy caused by a PPAR-α agonist of a fibrate, and has the effects of promoting fat burning, inhibiting fat synthesis, and inhibiting cell growth, thereby preventing liver dysfunction. [Selection figure] None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011105656-A |
| priorityDate |
2008-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |